a nurse is caring for a client who is receiving nitroglycerin iv and is switching to the oral form of the…

a nurse is caring for a client who is receiving nitroglycerin iv and is switching to the oral form of the medication. the nurse should identify that the oral dose will be higher than the iv dose for which of the following reasons?\nthe iv form crosses the blood - brain barrier.\nthe oral form has a decreased half - life.\nthe oral form has decreased bioavailability because of the first - pass effect.\nthe oral form has an increased rate of excretion.

a nurse is caring for a client who is receiving nitroglycerin iv and is switching to the oral form of the medication. the nurse should identify that the oral dose will be higher than the iv dose for which of the following reasons?\nthe iv form crosses the blood - brain barrier.\nthe oral form has a decreased half - life.\nthe oral form has decreased bioavailability because of the first - pass effect.\nthe oral form has an increased rate of excretion.

Answer

Brief Explanations:

To solve this, we analyze each option:

  1. The IV form crossing the blood - brain barrier is not related to the difference in doses between IV and oral nitroglycerin for this context.
  2. The oral form of nitroglycerin actually has a shorter half - life, but this does not explain why the oral dose needs to be higher.
  3. The first - pass effect occurs when a drug is absorbed from the gastrointestinal tract and then passes through the liver, where a significant portion of the drug is metabolized before it reaches the systemic circulation. This leads to decreased bioavailability of the oral form. So, to achieve the same therapeutic effect as the IV form (which has 100% bioavailability as it bypasses the first - pass effect), a higher oral dose is required.
  4. An increased rate of excretion of the oral form would not explain the need for a higher oral dose. It would rather suggest a lower or similar dose if excretion is higher, which is not the case here.

Answer:

The oral form has decreased bioavailability because of the first - pass effect.